<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR11">
 <label>11.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhang</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>MJ</given-names>
   </name>
   <name>
    <surname>Chandler</surname>
    <given-names>LA</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Lam</surname>
    <given-names>DM</given-names>
   </name>
  </person-group>
  <article-title>The first approved gene therapy product for cancer Ad-p53 (gendicine): 12 years in the clinic</article-title>
  <source>Hum Gene Ther.</source>
  <year>2018</year>
  <volume>29</volume>
  <issue>2</issue>
  <fpage>160</fpage>
  <lpage>179</lpage>
  <pub-id pub-id-type="doi">10.1089/hum.2017.218</pub-id>
  <pub-id pub-id-type="pmid">29338444</pub-id>
 </element-citation>
</ref>
